Clinical Trial Update: Trial of Nivolumab as a Novel Neoadjuvant Pre-Surgical Therapy for Locally Advanced Oral Cavity Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated nivolumab as neoadjuvant pre-surgical therapy for locally advanced oral squamous cell carcinoma. The study has completed and results w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Squamous Cell Carcinoma

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Oral Cavity SCC | Phase 2 | Status: COMPLETED | Results posted: 2025-11-12